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The hair follicle undergoes a cycle of growing, regressing, 
and resting phases (anagen, catagen, telogen, respectively). 
As the follicle enters catagen, the cells of the lower, cycling 
portion undergo a process of controlled cell death (apopto-
sis) . Understanding the mechanism of apoptosis in the folli-
cle should give insight into one of the control steps of hair 
cycling. In this study we sought the expression of bcl-2, a 
protooncogene associated with apoptosis control, in the cy-
cling follicle of the adult mouse. Using a monoclonal anti-
body to the mouse protein we immunolocalized bcl-2 gene 
product in the cycling pelage follicle of the C57/B6 adult 
T he hair follicle is unique in that it undergoes cycles of growth, regression, and rest throughout adult life. That the hair follicle manifests predictable cycles pro-gressing from a quiescent phase to an active growing phase implies that a portion of this structure is perma-
nent and remains responsive, throughout the lifetime of the orga-
nism (or at least as long as a given follicle can cycle), to the signal 
which reinitiates that cycle. Indeed, two portions of the follicle have 
been implicated as pivotal to the cycle and each has its advocates for 
the region of greater significance [1-:-3] . The stem ~ell theory of the 
follicle, put forth by the laboratones of Lavker and Sun [1,4,5], 
asserts that there is a long-lived population of cells in the bulge area 
of the follicle which, when given the proper stimulus, generates the 
new inferior, cycling portion of the follicle . The second theory, 
championed by the teams of Oliver, Reynolds, Jahoda, and Messen-
ger [2,6 -13] asserts that a long-lived epithelial cell in the follicle is 
of secondary importance to a well-preserved mesenchymal signal. 
This signal, arising from the follicular papilla, can also induce folli-
cle growth from epithelium that is not usually associated with hair 
formation [2]. Both theories are based on the idea that at least one 
cell type must be protected from cell death in order for the follicle to 
recycle. That lower follicle epithelial cells undergo extensive pro-
grammed cell death, apoptosis, at the end of the growth phase [14] 
necessarily means that the cells in this region are not among the 
long-lived cells of the follicle. This biologic dilemma, not unique to 
hair, raises the question how a biologic process can destroy a struc-
ture and yet preserve its ability to regenerate. Some insight into this 
issue should be found upon elucidating the molecular controls of 
follicular apoptosis. 
Apoptosis, in contrast to necrosis, describes a basic physiologic 
process of controlled cell death that plays a major role in regulating 
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mouse. The protein was expressed in the follicular papilla (a 
non-cycling portion of the follicle) throughout the cycle-in-
cluding telogen. The cycling follicular epithelium, however, 
showed positive antibody staining in anagen, which de-
creased in catagen and disappeared in telogen. In anagen the 
cells of the bulb, bulge, and basal layer of the outer root 
sheath expressed the bcl-2 protein. Understanding the action 
of this apoptosis-inhibiting molecule should serve to eluci-
date the dynamics of follicular cycling. ] Invest Dermotol 
103:107-111,1994 
the populations of many different cell types in different tissues (as 
reviewed in [15 -19]) . Morphologically, apoptosis occurs in two 
stages: in the first, there is nuclear and cytoplasmic condensation 
followed by fragmentation; in the second, the cell fragments are 
rapid ly phagocytosed by adjacent cells be they monocyte/phago-
cytic, endothelial, epidermal, or tumor cells. During embryologic 
development the process of apoptosis is used to shape developing 
systems, e.g. neural, lymphoid, limb bud, etc. In the adult, terminal 
differentiation systems also exploit apoptosis, e.g. hair follicle and 
epidermis [14,20] . 
Weare beginning to recognize, from the systems we know best, 
that the signals initiating, and the pathways leading to, apoptosis are 
legion, and that they vary from system to system. Signals that initi-
ate the apoptotic process range from the presence or absence of a 
cytokine, specific cell-cell interactions, exposure to trauma, surgery, 
toxins, hyperthermia, etc. [21]. The molecular steps whereby the 
apoptotic signal is transduced into cell death are unknown even 
though a series of associated proteins (or genes) have been impli-
cated [18,22]' 
A number of proteins have been identified which affect the apop-
totic process (as reviewed in [22,23]). One of these is the bc1-2 gene 
product. The subject of a recent review [24], this gene was found as 
the t( 14: 18) translocation product in the most common form of 
follicular B cell lymphoma [25 - 27]. This translocation subjects the 
bcl-2 gene to the regulation of the potent immunoglobulin heavy 
chain locus resulting in overexpression of the oncogene. The bc1-2 
gene encodes a 25-kD protein with sequence similarity to a small 
group of proteins which appear to play a role in cell differentiation 
[28]. In the laboratory it was found that overexpression of this gene 
prevented lymphoid cells from undergoing growth factor-
deprived, or glucocorticoid induced, apoptosis [29,30]. The bcl-2 
protein has been most convincingly localized to mitochondria, en-
doplasmic reticulum, and nuclear membranes [29-33]. Precisely 
how bcl-2 represses apoptosis is unknown but recent evidence indi-
cates it may function by regulating an anti-oxidant pathway [34]. 
Because bc1-2 expression has been linked to apoptosis and because 
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Figure 1. Immunoblot of mouse telogen and anagen skin extr~ct compared 
to mouse spleen protein extract, stained with the hamster antnnouse bcl:2 
antibody. Sites of molecular weight markers are noted on the left. Protem 
extracts arc from spleen (S, the positive control), intestine (I, the negative 
control), and skin, anagen (A) and telogen (T). 
apoptosis is central to catag~n, we ask~d if, v.:here, and when this 
protein might be expressed m the cyclmg folhcle of the adult. We 
found that the protein was expressed in the growing portions of the 
follicle during anagen and is expressed in the follicular papilla 
throughout the cycle. 
MATERIALS AND METHODS 
Chemicals Unless otherwise stated, all chemicals were reagent grade or 
better, purchased from Sigma Chemical Co. (St Louis, MO). Protein con-
centration was determined in solution by the Bradford assay [35] using 
Biorad reagents (Richmond, CAl and a BSA standard. Relative protein con-
centrations were determined by blot densitometry (pDi Quantiry One Soft-
ware, Huntington Station, NY). 
Animals Syngeneic C57 B6 female mice (purchased from Charles River, 
Kingston, NY), 7 - 10 weeks old, were housed under 12 h light/dark cycles 
and fed ad libitum. 
Anagen Induction Hair growth (anagen) was induced as previously de-
scribed [36). At the initiation of the experiment each animal was anesthe-
tized (pentobarbitol, 30 mg/kg) and its back pelage painted with warm 
beeswax/rosin (50%: 50%). After the wax/rosin layer hardened, it was 
peeled off taking with it the underlying hair. The time of hair shaft removal 
was taken as the time of anagen induction. Because there is no melanocytic 
pigmentation in the truncal epidermis of these animals and since follicu lar 
melanogenesis starts slightly after hair growth initiation, in this model we 
are able to assess anagen grossly by the temporal increase in skin pigmenta-
tion (i.e., darkening). Telogen is identified when the skin pigmentation 
again lightens. Histologic and kinetic corroboration of this interpretation 
has been given [36]. 
Antibody Production The preparation of the hamster anti mouse bcl-2 
antibody has been described [37]. Briefly, recombinant bcl-2, 25 kD, was 
generated from the pMON5743 expression vector usingJM103 Escltericllia 
coli. The protein band was isolated by sodium dodecylsulfate-poly-
acrylamide gel electrophoresis (SDS - PAGE) from the bacterial lysate. Ar-
menian hamsters were immunized with the protein and hybridomas were 
prepared from spleen cells by standard monoclonal antibody techniques. 
Productive clones were identified by dot blots and then confirmed by West-
ern electrophoretic analysis. Positive clones were subcloned 3X and re-
screened. 
Immunolocalization At various times after follicle growth induction, 
mice were sacrificed and the back skin (vertebral/paravertebral) taken for 
histology. The skin was immediately embedded in O.C.T. (Miles, Eckhart, 
IN), frozen and sectioned (7 11m) by cryostat (Microm Gmbh., Heidelberg, 
Germany). Sections were fixed in cold (4°C) acetone, rinsed in phosphate-
buffered saline (PBS) and quenched in 2% H 20 2/methanol for 1 h. Tissues 
were blocked for endogenous avidin and biotin (15 min; blocking kit, Vec-
tor, Burlingame, CAl and for non-specific background with 1% bovine 
serum albumin, 1 % milk (Carnation Powdered) in PBS for 30 min followed 
by 100% goat serum for 30 min. The tissue slides were flooded with the 
monoclonal hamster anti-mouse bcl-2 antibody, routinely at a dilution of 
1: 10 in 1% BSA/l% milk in PBS overnight at 4°C in a humidiry (100% 
H 20) chamber. Sections were rinsed 3X with cold PBS and then flooded 
with the secondary antibody (biotinylated goat anti-hamster) and the ter-
tiary antibody (biotinylated swine anti-goat) both from Cal tag (South San 
Francisco, CAl. Secondary and tertiary antibodies were each diluted 1 : 50 in 
1 % BSA/l % milk in PBS and incubated on the sections for 30 min at room 
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Figure 2. Mouse skin of one day anagen stained with anti-bcl-2 antibody. 
The epithelial peg of the lower follicle is positive as is the papilla (a); similar 
staining is not found in the negative control (b). Bar, 150 11m. 
temperature. Finally, the tissue was exposed to a streptavidin-peroxidase 
complex (Zymed, South San Francisco, CAl diluted 1 : 20 in 1 % BSA/l % 
milk at room temperature. Sections were washed copiously with PBS be-
tween antibody exposures. Label detection was accomplished by exposing 
the sections to a diaminobenzamidine solution (1 mg/ml PBS). Sections 
were briefly counterstained (1 % methyl green/alcian blue, Rowley Bio-
chern., Rowley MA/ Aldrich, Milwaukee, WI), dehydrated (graded alcohols 
and xylenes), and mounted (Histomount, National Diagnostics, Somerville, 
NJ). Controls run in parallel with every experiment consisted of all steps 
except for a substituted irrelevant primary antibody or for the omission of a 
primary antibody. 
Western Blotting Full thickness skin was collected at various intervals 
after anagen induction (the panniculus carnosus was removed by gentle 
scalpel scraping), and homogenized (Polytron PT 3000, Brinkmann; at 
2000 rpm 3 X 30 seconds) in a denaturing buffer (1% Triton X-100, 
50 mM NaCI, 10 mM Tris pH 7.6, 5 mM ethylenediamine tetraacetic acid 
and a protease inhibitor cocktail [38) . SDS - PAGE was performed [39] 
using 200 Ilg of total skin protein per lane (gradient gel, 10 - 20%, Enpro-
tech, Integrated Separation Systems, Natick, MA) and transferred by elec-
troblotting overnight to nitrocellulose membrane as previously described 
[40]. The blotted membrane was blocked in a 10% milk/0.05% Tween-20/ 
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Figure 3, Mouse skin of 3 d anagen stained with anti-bcl-2 antibody (aJ . 
The follicular epithelium of the lower follicle as we ll as the basal layer of the 
epidermis is positive. Compare to the negative control (b). Bar, 150 11m. 
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Figure 4. Mouse skin of8 d anagen stained with anti bcl-2 antibody (a). At 
this time the epithelium of the bulb, the basal layer of the outer root sheath, 
the bulge, and the cells of the follicular papilla are positive. The negative 
control is shown in (b) . Bar, 150 11m. 
PBS solution overnight followed by 1 h incubation in goat serum. The 
membrane was then incubated in a 1 : 10 dilution of bcl-2 hal11ster anti-
mouse monoclonal antibody in PBS overnight at 4 ·C. After washing 3X in 
PBS plus 0.05% Twee~-20 (PB?T), the membranes :were incubated with 
goat anti-hamster peroxidase conjugated secondary antibody (Calta~; 1 : 2.00 
dilution in PBST) for 1 h at room temperature. After 4X washll1g with 
PBST, detection was accomplished with the ECL system (Amersham, Ar-
lington Heights, IL) according to the manufacturer's instructions. 
RESULTS 
characterization of the Monoclonal Antibody The hamster 
monoclonal antimouse bcl-2 antibody detected a 25-kD band on 
Western blot analysis of tissues known to contain bcl-2 protein 
(spleen, Fig 1, lane 1); the band was not found in tissues which lack 
this protein (intestine, Fig 1, lane 2). Occasionally, but inconsist-
ently, a doublet due to an equally staining partner of slightly less 
mobility was found . 
bcl-2 Expression in Whole Skin Analysis of skin samples by 
Western blots revealed a 25-kD band (Fig 1,lanes A and T) identical 
to the control tissues (Fig 1, la/Ie S). When the content of bcl-2 
antigen in anagen (8 d) versus telogen skin was compared by densi-
tometry, it was found that telogen skin contained less than 2.0% of 
that found in anagen. This could reflect both the differential thick-
ness of anagen and telogen skin and/or the differential content of 
the protein in growing and resting follicles. 
Immunolocalization During the Cycle To investigate the lo-
calization ofbcl-2 protein in the hair follicle throughout the differ-
ent growth phases we analyzed the complete hair cycle immunohis-
tochemically by taking back skin samples daily over 26 dafter 
initiation of the cycle. At the cellular level the antigen localized to 
the cytoplasm of skin cells. This distribution is consistent with the 
mitochondrial localization reported for this protein earlier [29]. 
We found that not only the quantity ofbcl-2 protein but also the 
localization within the follicle was cycle phase dependent (Figs 
2-7). Throughout the cycle, from one rest period to the next, the 
follicular papilla (a critical mesenchymal portion of the follicle) was 
the only region that was consistently positive (Figs 2 - 7). The cyto-
plasm of the papilla cells was positive in all phases (Figs 6 and 7) . 
The follicular epithelium was negative in telogen (Fig 6a,b) . The 
antigen was first detected in the follicular epithelium during early 
anagen (1 d, Fig 2a) becoming progressively stronger by day 3 (Fig 
3a). By full anagen the bulb, basal cells of the outer root sheath, and 
the bulge expressed the antigen (day 8, Fig 4a, and Fig 7). In cata-
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Figure 5. Mouse skin of 19 d after hair growth induction stained with 
anti-bcl-2 antibody (a). At this time the hair follicles are in catagen and 
staining of the follicle epithelium is reduced while staining of the papilla 
remains strong. In the control preparation (b) it is notable that there is 
prominent background staining of the outer epidermis, an irregular finding 
in this study. Bar, 75 Jl.111. 
gen, the density of staining decr.eased along an apparent gradient 
from the bulb distally outward (Fig Sa) . Finally, in telogen all stain-
ing of the epithelium ceased (Fig 6a,b). It was notable that during 
catagen, staining of the bulge area was reduced, and then became 
negative in telogen. Cyclic changes of bcl-2 antigen expression in 
other skin structures, such as epidermis, sebaceous gland, etc., were 
not appreciated though we did observe the expected morphologic 
changes in them.that one usually ob.serves over the cycle [41]. 
In all preparations there was Rerslstent, positive staining of the 
granular/splllous layers of the epidermis (e.g., Fig 5b). Attempts to 
Figure 6. Mouse skin of 20 d after hair growth induction shows late cata-
gen/early telogen phase (a,b). At cilis time the only significant staining is 
present in the papilla. Bar, 75 Jl.I11, a; 38 !£111, b. 
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Figure 7. Mouse pelage hair follicle of 8 d after hair growth induction. As 
also seen in Fig 4 the antigen localizes to the bulb, the basal layer of the outer 
toot sheath, the bulge (BIg) and the fo ll icular papilla, as well as scattered 
dermal connective tissue cells. Bar, 26 jlm. 
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reduce this staining, by increasing the time of blocking, by increas-
ing the concentration, or varying the character of the protein blot, 
were all without avail. Staining of the basal cells of the epidermis 
was in general weak but, in some cases, clearly positive. The latter 
observation is consistent with the reports of others [42,43]. 
DISCUSSION 
In this study, we found that bcl-2 is expressed in the adult cycling 
hair follicle. That it is found at all is interesting because 1) apoptosis 
is central to the hair cycle and 2) this protooncogene has been found 
to playa profound role in blocking the apoptosis occurring in other 
systems. Although bcl-2 is expressed throughout the cycle in the 
follicular papilla, its expression in the fol1icular epithelium is de-
pendent upon the phase of the cycle. In anagen it is expressed in the 
epithelium of the most actively growing portions of the cycling 
foUicle, the bulb, basal layer of the outer root sheath and bulge 
region, but in telogen it is absent in the epithelium of the resting 
foUicle, including the bulge. The residual bcl-2 found in telogen, 
morphological1y and by Western blot analysis, is due largely to that 
within the fol1icular papiUa, the mesenchymal portion of the folli-
cle. It is notable, though, that some of the dermal stromal cells are 
also bcl-2 positive (Fig 7). 
bcl-2 expression has been studied in adult and some fetal tissues 
[42,43]. The antigen was found in thymus, hematopoietic cells, 
endocrine, or hormonally regulated tissues that undergo hyperpla-
sia and involution, as wel1 as the stem cel1 population of several 
complex epithelia, like the basal layer of skin. In both these former 
studies it was concluded that bcl-2 could serve to maintain the 
stem-cel1 pool by protecting the stem cel1s from post-mitotic differ-
entiation, eventual senescence, and final1y death. 
That the cel1s of the bulge express bcl-2 during anagen, but then 
do not during telogen, is a confusing finding at this time. A priori, 
one would predict that the presumptive stem cells in this structure 
would express this protein at all times to assure their survival and 
thus their ability to generate the cells, and thus the structure, of the 
next cycle. One interpretation may be that bcl-2 in the follicle plays 
a different role from that in the lymphoid system. Relevant to this 
point is that amongst T cells bcl-2 is expressed in some phases of 
differentiation and not in others [44,45]. A second possibility is that 
another apoptosis-preventing function is at work in the bulge area 
distinct from bcl-2, a possibility compatible with the alleged normal 
hair of the bcl-2 deficient mouse [46] . Undoubtedly, there are other 
cellular components which inhibit apoptosis [23] . The trivial expla-
nation is that our methods are not sensitive enough to visualize the 
few important stem cells that, in fact, do retain this protein 
throughout the cycle. 
That the papilla continues to express bcl-2 throughout the cycle, 
as well as during telogen, supports the notion that this structure is 
long-lived as demonstrated long ago [47], and that its function is 
continuously necessary [48]. This finding, together with the obser-
vation that it will induce follicle formation from epithelium, which 
is usual1y not associated with follicles, e.g., palm [2], gives sup-
port to the argument that this structure is the central organizing 
focus. 
In this study, we have demonstrated that a protooncogene that 
blocks apoptosis in several systems is expressed in the cycling adult 
hair follicle. That it is expressed in the epithelium only during the 
growth phase but is present in the mesenchyme, the papilla, during 
the whole cycle suggests that the papilla is the stable structure of 
the follicle during the cycle. Elucidating the molecular controls 
for the expression and action of this interesting molecule should 
offer insight into the events regulating the cessation of follicle 
growth. 
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